Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Keane Converts 173,838 Class B Shares in Astronics

Director Robert S. Keane filed a Form 4 with the SEC on November 4, 2026, disclosing a conversion of 173,838 Class B shares of Astronics Corp into common stock on November 3, 2026, through Boston & Saranac LLC.

Manish Choudhary | 04 November 2026

Barry Sells 7,195 Stoke Therapeutics Shares on Nov. 2

Barry Ticho, Chief Medical Officer of Stoke Therapeutics, Inc., filed a statement of changes in beneficial ownership on November 4, 2026, disclosing the sale of 7,195 shares of common stock on November 2, 2026.

Aditi Sarkar | 04 November 2026

Tryforos Buys 3,000 Credit Acceptance Shares at $485.20

Director Thomas N. Tryforos filed a Form 4 with the SEC on November 4, 2026, disclosing a purchase of 3,000 shares of Credit Acceptance Corp common stock on November 2, 2026, through TNT Investments LLC.

Aditi Sarkar | 04 November 2026

Raabe Sells 598 GNRC Shares Under 10b5-1 Plan

Kyle Andrew Raabe, President of Home Power Generation at Generac Holdings Inc., filed a Form 4 on November 4, 2026, disclosing stock option exercise and share sale transactions dated November 3, 2026, executed under a Rule 10b5-1(c) plan.

Manish Choudhary | 04 November 2026

Lucid Director Ori Winitzer Sells 1,000 Shares at $3.09

Lucid Group, Inc. director Ori Winitzer filed a Form 4 on November 4, 2026, disclosing the sale of 1,000 shares of Class A Common Stock on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.

Anjali Anand | 04 November 2026

Patrick Fisher Sells 150 Orthofix Shares at $9.07

Patrick Fisher, President of Global Limb Recon at Orthofix Medical Inc., filed a Form 4 on November 4, 2026, disclosing a sale of 150 shares of common stock on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.

Shwetambri Chauhan | 04 November 2026

Frances Arnold Sells 11,409 GENB Shares at $16.19

Director Frances Arnold filed a Form 4 with the SEC on November 4, 2026, disclosing the sale of 11,409 shares of Generate Biomedicines, Inc. common stock on October 29, 2026, under a pre-established Rule 10b5-1 trading plan.

Aditi Sarkar | 04 November 2026

Kliger Exercises 18,237 Options and Sells Shares in LuxExperience

Michael Kliger, Chief Executive Officer of LuxExperience B.V. (NASDAQ:LUXE), filed a Form 4 on November 4, 2026, disclosing option exercises and open-market sales of ordinary shares on November 2 and November 3, 2026.

Aditi Sarkar | 04 November 2026

CareDx Director Cohen Disposes 25,000 Shares via Gift

Director Fred E. Cohen filed a Form 4 with the SEC on November 4, 2026, disclosing a disposition of 25,000 shares of CareDx, Inc. common stock on November 3, 2026, via a gift transaction.

Shwetambri Chauhan | 04 November 2026

Susan Snow Gets 13,595 NeoVolta Shares on Oct 19, 2026

Director Susan H. Snow filed a Form 4 with the SEC on November 4, 2026, disclosing two acquisitions of NeoVolta Inc. common stock issued in connection with Board of Director services, held indirectly through The Susan Hegarty Snow Trust.

Manish Choudhary | 04 November 2026
Support

Hi! How can we help you today?

Loading…